CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $427.41 | $3.4M | 0 |
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 70,500 | ||
| 2025-10-20 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 1,750 | ||
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,599 | $421.04 | $673K | 2,531 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $422.30 | $84K | 2,331 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,301 | $424.68 | $553K | 1,030 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $427.56 | $171K | 630 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $434.22 | $217K | 130 |
| 2025-10-20 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 170,000 | ||
| 2025-10-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,900 | $430.05 | $1.2M | 1,230 |
| 2025-10-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,100 | $432.31 | $476K | 130 |
| 2025-10-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 174,000 | ||
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,908 | $428.51 | $818K | 45,873 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,092 | $429.61 | $469K | 44,781 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −955 | $430.59 | $411K | 43,826 |
| 2025-10-16 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,516 | $431.72 | $1.1M | 41,310 |
Page 191 of 214 · 4,273 trades